Kovack Advisors, Inc. Northwest Biotherapeutics Inc Transaction History

Kovack Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.63 - $1.91 $6,300 - $19,100	-10,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.7 - $0.98 $7,000 - $9,800	10,000 New	10,000 $6,000
Q3 2021 Nov 03, 2021	SELL	$1.1 - $1.49 $27,500 - $37,250	-25,000 Closed	0 $0
Q2 2021 Jul 29, 2021	BUY	$1.29 - $1.95 $32,250 - $48,750	25,000 New	25,000 $37,000
Q1 2014 Jan 28, 2019	SELL	N/A	-11,978 Closed	0 $0

Q4 2013 Mar 15, 2019	SELL	N/A	-738 Reduced 5.8%	11,978 $45,000
Q3 2013 Apr 09, 2019	SELL	N/A	-4,229 Reduced 24.96%	12,716 $43,000
Q2 2013 May 07, 2019	BUY	N/A	16,945	16,945 $57,000

625K

Ticker NWBO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,037,230,016
Market Cap $436M
Description
Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, wh...

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.